Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2025-12-25 @ 3:08 AM
NCT ID:
NCT00114933
Eligibility Criteria:
Inclusion Criteria:
* HIV patients \> 18 years old who provide signed and dated Informed consent.
* HIV patients who have been receiving lopinavir/ritonavir and two nucleosides during at least 4 weeks.
* Plasma HIV RNA \< 50 cop/ml for six months
Exclusion Criteria:
* HIV patients who have stopped a protease inhibitor due to virological failure.
* HIV patients with hepatic or renal insufficiency.
* HIV patients with positive serum HBVAg
* HIV patients who require treatment with a lopinavir/r contraindicated medication.
* HIV pregnant or breastfeeding women.
* Active drug abuse (including alcohol or recreational drugs). Exception, cannabis, provided the investigator is confident in patient adherence. Patients under Methadone program will be accepted too if deemed appropriate by the investigator.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00114933
Study Brief:
Protocol Section:
NCT00114933